Role of Paclitaxel in Stricture Urethra
- Conditions
- Stricture Urethra
- Interventions
- Procedure: DVIUProcedure: DVIU with paclitaxel injection
- Registration Number
- NCT05678413
- Lead Sponsor
- Al-Azhar University
- Brief Summary
Stricture urethra is a common disease and has various causing factors. The most common performed procedure is direct visual internal urethrotomy (DVIU), but unfortunately has a high recurrence rates. Multiple trial were performed to improve the outcomes of DVIU. Various intralesional injections were used. in this trial we will evaluate intralesional paclitaxel injection following DVIU.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 200
- Anterior urethral stricture
- Short strictures (less than 2 cm)
- International Prostate Symptom Score less than 11 and maximum flow rate < 15 ml per second.
- No previous treatment for stricture disease
- Recurrent cases
- Prior pelvic radiation
- Associated other pathology or unresolved confounding etiologies (e.g. bladder neck contracture, neurogenic bladder, benign prostatic hyperplasia) were excluded.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description DVIU DVIU Cystourethroscopy will be performed using a 22 Fr rigid cystoscope to allow for ureteric catheter 3F/a wire to be passed through the stricture and into the urinary bladder. DVIU will be performed by cold-knife incisions at the 12-, 3-, and 9 o'clock positions through the full thickness of the fibrosis to healthier appearing tissue. DVIU with paclitaxel DVIU with paclitaxel injection Cystourethroscopy will be performed using a 22 Fr rigid cystoscope to allow for ureteric catheter 3F/a wire to be passed through the stricture and into the urinary bladder. DVIU will be performed by cold-knife incisions at the 12-, 3-, and 9 o'clock positions through the full thickness of the fibrosis to healthier appearing tissue. A 23 Fr Wolf (Vernon Hills, IL) injection scope and a standard injection needle was used to inject 30 mg/5mL of paclitaxel vial, 1.5 mL will be injected along the length of each incision into healthier appearing tissue for a total of 5 mL.
- Primary Outcome Measures
Name Time Method Success of treatment 1 year Treatment free rates (Freedom from repeat intervention e.g., repeat dilation, DVIU or urethroplasty).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mohamed Fawzy Salman
🇪🇬Cairo, Egypt